Lundbeck ups guidance on higher expectations for Rexulti, Vyepti

Lundbeck’s shares rose around 5% on Tuesday as the company bumped up its annual guidance on higher expectations for Rexulti and Vyepti in the US, as well as demand for Brintellix/Trintellix in Europe and Asia. CEO Charl van Zyl said the company's “excellent” showing in the first half, was "driven by the continued strong performance of our strategic brands [which allowed] us to raise the guidance.”